end functions for video ads moving left and right


--DocBreak--
Costco Wholesale Corporation [COST] has 444.88M shares outstanding, amounting to a total market cap of 126.76B. Its stock price has been found in the range of 233.05 to 325.26. At its current price, it has moved down by -12.40% from its 52-week high, and it has moved up 22.27% from its 52-week low.


--DocBreak--
Complete study of the global Board Mount Connectors market is carried out by the analysts in this report, taking into consideration key factors like drivers, challenges, recent trends, opportunities, advancements, and competitive landscape. This report offers a clear understanding of the present as well as future scenario of the global Board Mount Connectors industry. Research techniques like PESTLE and Porter's Five Forces analysis have been deployed by the researchers. They have also provided accurate data on Board Mount Connectors production, capacity, price, cost, margin, and revenue to help the players gain a clear understanding into the overall existing and future market situation.


--DocBreak--
In the long term, there are strategic steps manufacturers can take to reduce drug shortages. Decentralizing supply chains could help counter upstream disruptions. Rather than producing a drug in a single plant, companies could distribute production across multiple plants, ideally in different areas of the world. This could prevent a single problem from affecting the entire supply.


--DocBreak--
Keep your eyes peeled for the next scheduled financial results to be made public for this company, which are scheduled to be released on 04/20/2020.


--DocBreak--
functions for moving video ads to left and right


--DocBreak--
X-Backend-State: Backend up and running


--DocBreak--
International Business Machines Corporation [IBM] has 916.83M shares outstanding, amounting to a total market cap of 96.71B. Its stock price has been found in the range of 90.56 to 158.75. At its current price, it has moved down by -33.56% from its 52-week high, and it has moved up 16.48% from its 52-week low.


--DocBreak--
Table of Contents   Executive Summary 1 Hemostats and Tissue Sealants Market Overview   1.1 Product Overview and Scope of Hemostats and Tissue Sealants   1.2 Hemostats and Tissue Sealants Segment by Type   1.2.1 Global Hemostats and Tissue Sealants Production Growth Rate Comparison by Type (2014-2025)   1.2.2 Hemostats   1.2.3 Tissue Sealants   1.3 Hemostats and Tissue Sealants Segment by Application   1.3.1 Hemostats and Tissue Sealants Consumption Comparison by Application (2014-2025)   1.3.2 Clinical Medicine   1.3.3 Scientific Research   1.4 Global Hemostats and Tissue Sealants Market by Region   1.4.1 Global Hemostats and Tissue Sealants Market Size Region   1.4.2 North America Status and Prospect (2014-2025)   1.4.3 Europe Status and Prospect (2014-2025)   1.4.4 China Status and Prospect (2014-2025)   1.4.5 Japan Status and Prospect (2014-2025)   1.5 Global Hemostats and Tissue Sealants Market Size   1.5.1 Global Hemostats and Tissue Sealants Revenue (2014-2025)   1.5.2 Global Hemostats and Tissue Sealants Production (2014-2025) 2 Global Hemostats and Tissue Sealants Market Competition by Manufacturers   2.1 Global Hemostats and Tissue Sealants Production Market Share by Manufacturers (2014-2019)   2.2 Global Hemostats and Tissue Sealants Revenue Share by Manufacturers (2014-2019)   2.3 Global Hemostats and Tissue Sealants Average Price by Manufacturers (2014-2019)   2.4 Manufacturers Hemostats and Tissue Sealants Production Sites, Area Served, Product Types   2.5 Hemostats and Tissue Sealants Market Competitive Situation and Trends   2.5.1 Hemostats and Tissue Sealants Market Concentration Rate   2.5.2 Hemostats and Tissue Sealants Market Share of Top 3 and Top 5 Manufacturers   2.5.3 Mergers & Acquisitions, Expansion 3 Global Hemostats and Tissue Sealants Production Market Share by Regions   3.1 Global Hemostats and Tissue Sealants Production Market Share by Regions   3.2 Global Hemostats and Tissue Sealants Revenue Market Share by Regions (2014-2019)   3.3 Global Hemostats and Tissue Sealants Production, Revenue, Price and Gross Margin (2014-2019)   3.4 North America Hemostats and Tissue Sealants Production   3.4.1 North America Hemostats and Tissue Sealants Production Growth Rate (2014-2019)   3.4.2 North America Hemostats and Tissue Sealants Production, Revenue, Price and Gross Margin (2014-2019)   3.5 Europe Hemostats and Tissue Sealants Production   3.5.1 Europe Hemostats and Tissue Sealants Production Growth Rate (2014-2019)   3.5.2 Europe Hemostats and Tissue Sealants Production, Revenue, Price and Gross Margin (2014-2019)   3.6 China Hemostats and Tissue Sealants Production (2014-2019)   3.6.1 China Hemostats and Tissue Sealants Production Growth Rate (2014-2019)   3.6.2 China Hemostats and Tissue Sealants Production, Revenue, Price and Gross Margin (2014-2019)   3.7 Japan Hemostats and Tissue Sealants Production (2014-2019)   3.7.1 Japan Hemostats and Tissue Sealants Production Growth Rate (2014-2019)   3.7.2 Japan Hemostats and Tissue Sealants Production, Revenue, Price and Gross Margin (2014-2019) 4 Global Hemostats and Tissue Sealants Consumption by Regions   4.1 Global Hemostats and Tissue Sealants Consumption by Regions   4.2 North America Hemostats and Tissue Sealants Consumption (2014-2019)   4.3 Europe Hemostats and Tissue Sealants Consumption (2014-2019)   4.4 China Hemostats and Tissue Sealants Consumption (2014-2019)   4.5 Japan Hemostats and Tissue Sealants Consumption (2014-2019) 5 Global Hemostats and Tissue Sealants Production, Revenue, Price Trend by Type   5.1 Global Hemostats and Tissue Sealants Production Market Share by Type (2014-2019)   5.2 Global Hemostats and Tissue Sealants Revenue Market Share by Type (2014-2019)   5.3 Global Hemostats and Tissue Sealants Price by Type (2014-2019)   5.4 Global Hemostats and Tissue Sealants Production Growth by Type (2014-2019) 6 Global Hemostats and Tissue Sealants Market Analysis by Applications   6.1 Global Hemostats and Tissue Sealants Consumption Market Share by Application (2014-2019)   6.2 Global Hemostats and Tissue Sealants Consumption Growth Rate by Application (2014-2019) 7 Company Profiles and Key Figures in Hemostats and Tissue Sealants Business   7.1 Baxter   7.1.1 Baxter Hemostats and Tissue Sealants Production Sites and Area Served   7.1.2 Hemostats and Tissue Sealants Product Introduction, Application and Specification   7.1.3 Baxter Hemostats and Tissue Sealants Production, Revenue, Price and Gross Margin (2014-2019)   7.1.4 Main Business and Markets Served   7.2 CR Bard   7.2.1 CR Bard Hemostats and Tissue Sealants Production Sites and Area Served   7.2.2 Hemostats and Tissue Sealants Product Introduction, Application and Specification   7.2.3 CR Bard Hemostats and Tissue Sealants Production, Revenue, Price and Gross Margin (2014-2019)   7.2.4 Main Business and Markets Served   7.3 Johnson & Johnson   7.3.1 Johnson & Johnson Hemostats and Tissue Sealants Production Sites and Area Served   7.3.2 Hemostats and Tissue Sealants Product Introduction, Application and Specification   7.3.3 Johnson & Johnson Hemostats and Tissue Sealants Production, Revenue, Price and Gross Margin (2014-2019)   7.3.4 Main Business and Markets Served   7.4 B.Braun   7.4.1 B.Braun Hemostats and Tissue Sealants Production Sites and Area Served   7.4.2 Hemostats and Tissue Sealants Product Introduction, Application and Specification   7.4.3 B.Braun Hemostats and Tissue Sealants Production, Revenue, Price and Gross Margin (2014-2019)   7.4.4 Main Business and Markets Served   7.5 Cardinal Health   7.5.1 Cardinal Health Hemostats and Tissue Sealants Production Sites and Area Served   7.5.2 Hemostats and Tissue Sealants Product Introduction, Application and Specification   7.5.3 Cardinal Health Hemostats and Tissue Sealants Production, Revenue, Price and Gross Margin (2014-2019)   7.5.4 Main Business and Markets Served   7.6 Cryolife   7.6.1 Cryolife Hemostats and Tissue Sealants Production Sites and Area Served   7.6.2 Hemostats and Tissue Sealants Product Introduction, Application and Specification   7.6.3 Cryolife Hemostats and Tissue Sealants Production, Revenue, Price and Gross Margin (2014-2019)   7.6.4 Main Business and Markets Served   7.7 Neomend   7.7.1 Neomend Hemostats and Tissue Sealants Production Sites and Area Served   7.7.2 Hemostats and Tissue Sealants Product Introduction, Application and Specification   7.7.3 Neomend Hemostats and Tissue Sealants Production, Revenue, Price and Gross Margin (2014-2019)   7.7.4 Main Business and Markets Served   7.8 Vivostat   7.8.1 Vivostat Hemostats and Tissue Sealants Production Sites and Area Served   7.8.2 Hemostats and Tissue Sealants Product Introduction, Application and Specification   7.8.3 Vivostat Hemostats and Tissue Sealants Production, Revenue, Price and Gross Margin (2014-2019)   7.8.4 Main Business and Markets Served   7.9 Z-Medica   7.9.1 Z-Medica Hemostats and Tissue Sealants Production Sites and Area Served   7.9.2 Hemostats and Tissue Sealants Product Introduction, Application and Specification   7.9.3 Z-Medica Hemostats and Tissue Sealants Production, Revenue, Price and Gross Margin (2014-2019)   7.9.4 Main Business and Markets Served 8 Hemostats and Tissue Sealants Manufacturing Cost Analysis   8.1 Hemostats and Tissue Sealants Key Raw Materials Analysis   8.1.1 Key Raw Materials   8.1.2 Price Trend of Key Raw Materials   8.1.3 Key Suppliers of Raw Materials   8.2 Proportion of Manufacturing Cost Structure   8.3 Manufacturing Process Analysis of Hemostats and Tissue Sealants   8.4 Hemostats and Tissue Sealants Industrial Chain Analysis 9 Marketing Channel, Distributors and Customers   9.1 Marketing Channel   9.1.1 Direct Marketing   9.1.2 Indirect Marketing   9.2 Hemostats and Tissue Sealants Distributors List   9.3 Hemostats and Tissue Sealants Customers 10 Market Dynamics   10.1 Market Trends   10.2 Opportunities   10.3 Market Drivers   10.4 Challenges   10.5 Influence Factors 11 Global Hemostats and Tissue Sealants Market Forecast   11.1 Global Hemostats and Tissue Sealants Production, Revenue Forecast   11.1.1 Global Hemostats and Tissue Sealants Production Growth Rate Forecast (2019-2025)   11.1.2 Global Hemostats and Tissue Sealants Revenue and Growth Rate Forecast (2019-2025)   11.1.3 Global Hemostats and Tissue Sealants Price and Trend Forecast (2019-2025)   11.2 Global Hemostats and Tissue Sealants Production Forecast by Regions (2019-2025)   11.2.1 North America Hemostats and Tissue Sealants Production, Revenue Forecast (2019-2025)   11.2.2 Europe Hemostats and Tissue Sealants Production, Revenue Forecast (2019-2025)   11.2.3 China Hemostats and Tissue Sealants Production, Revenue Forecast (2019-2025)   11.2.4 Japan Hemostats and Tissue Sealants Production, Revenue Forecast (2019-2025)   11.3 Global Hemostats and Tissue Sealants Consumption Forecast by Regions (2019-2025)   11.3.1 North America Hemostats and Tissue Sealants Consumption Forecast (2019-2025)   11.3.2 Europe Hemostats and Tissue Sealants Consumption Forecast (2019-2025)   11.3.3 China Hemostats and Tissue Sealants Consumption Forecast (2019-2025)   11.3.4 Japan Hemostats and Tissue Sealants Consumption Forecast (2019-2025)   11.4 Global Hemostats and Tissue Sealants Production, Revenue and Price Forecast by Type (2019-2025)   11.5 Global Hemostats and Tissue Sealants Consumption Forecast by Application (2019-2025) 12 Research Findings and Conclusion 13 Methodology and Data Source   13.1 Methodology/Research Approach   13.1.1 Research Programs/Design   13.1.2 Market Size Estimation   13.1.3 Market Breakdown and Data Triangulation   13.2 Data Source   13.2.1 Secondary Sources   13.2.2 Primary Sources   13.3 Author List   13.4 Disclaimer


--DocBreak--
If he is convicted as a first offender, he could face a maximum of 9 months imprisonment and a fine of 30 penalty units as per Australian law.


--DocBreak--
WASA call center to work round the clock


--DocBreak--
Honeywell International Inc. [HON] has 711.15M shares outstanding, amounting to a total market cap of 84.99B. Its stock price has been found in the range of 101.08 to 184.06. At its current price, it has moved down by -35.07% from its 52-week high, and it has moved up 18.23% from its 52-week low.


--DocBreak--
Emails will be sent directly from Legacy.com. We respect your privacy and will not sell your information to a third party. You may opt out at any time. See privacy policy for details.


--DocBreak--
Table of Contents   Executive Summary 1 Percutaneous Transhepatic Cholangiography Market Overview   1.1 Product Overview and Scope of Percutaneous Transhepatic Cholangiography   1.2 Percutaneous Transhepatic Cholangiography Segment by Type   1.2.1 Global Percutaneous Transhepatic Cholangiography Production Growth Rate Comparison by Type (2014-2025)   1.2.2 PTC Plastic Pancreatic & Biliary Stenting Procedures   1.2.3 PTC Metal Pancreatic & Biliary Stenting Procedures   1.3 Percutaneous Transhepatic Cholangiography Segment by Application   1.3.1 Percutaneous Transhepatic Cholangiography Consumption Comparison by Application (2014-2025)   1.3.2 Jaundice   1.3.3 Stone Removal   1.3.4 Postoperative or Posttraumatic Bile Leakage   1.3.5 Others   1.4 Global Percutaneous Transhepatic Cholangiography Market by Region   1.4.1 Global Percutaneous Transhepatic Cholangiography Market Size Region   1.4.2 North America Status and Prospect (2014-2025)   1.4.3 Europe Status and Prospect (2014-2025)   1.4.4 China Status and Prospect (2014-2025)   1.4.5 Japan Status and Prospect (2014-2025)   1.5 Global Percutaneous Transhepatic Cholangiography Market Size   1.5.1 Global Percutaneous Transhepatic Cholangiography Revenue (2014-2025)   1.5.2 Global Percutaneous Transhepatic Cholangiography Production (2014-2025) 2 Global Percutaneous Transhepatic Cholangiography Market Competition by Manufacturers   2.1 Global Percutaneous Transhepatic Cholangiography Production Market Share by Manufacturers (2014-2019)   2.2 Global Percutaneous Transhepatic Cholangiography Revenue Share by Manufacturers (2014-2019)   2.3 Global Percutaneous Transhepatic Cholangiography Average Price by Manufacturers (2014-2019)   2.4 Manufacturers Percutaneous Transhepatic Cholangiography Production Sites, Area Served, Product Types   2.5 Percutaneous Transhepatic Cholangiography Market Competitive Situation and Trends   2.5.1 Percutaneous Transhepatic Cholangiography Market Concentration Rate   2.5.2 Percutaneous Transhepatic Cholangiography Market Share of Top 3 and Top 5 Manufacturers   2.5.3 Mergers & Acquisitions, Expansion 3 Global Percutaneous Transhepatic Cholangiography Production Market Share by Regions   3.1 Global Percutaneous Transhepatic Cholangiography Production Market Share by Regions   3.2 Global Percutaneous Transhepatic Cholangiography Revenue Market Share by Regions (2014-2019)   3.3 Global Percutaneous Transhepatic Cholangiography Production, Revenue, Price and Gross Margin (2014-2019)   3.4 North America Percutaneous Transhepatic Cholangiography Production   3.4.1 North America Percutaneous Transhepatic Cholangiography Production Growth Rate (2014-2019)   3.4.2 North America Percutaneous Transhepatic Cholangiography Production, Revenue, Price and Gross Margin (2014-2019)   3.5 Europe Percutaneous Transhepatic Cholangiography Production   3.5.1 Europe Percutaneous Transhepatic Cholangiography Production Growth Rate (2014-2019)   3.5.2 Europe Percutaneous Transhepatic Cholangiography Production, Revenue, Price and Gross Margin (2014-2019)   3.6 China Percutaneous Transhepatic Cholangiography Production (2014-2019)   3.6.1 China Percutaneous Transhepatic Cholangiography Production Growth Rate (2014-2019)   3.6.2 China Percutaneous Transhepatic Cholangiography Production, Revenue, Price and Gross Margin (2014-2019)   3.7 Japan Percutaneous Transhepatic Cholangiography Production (2014-2019)   3.7.1 Japan Percutaneous Transhepatic Cholangiography Production Growth Rate (2014-2019)   3.7.2 Japan Percutaneous Transhepatic Cholangiography Production, Revenue, Price and Gross Margin (2014-2019) 4 Global Percutaneous Transhepatic Cholangiography Consumption by Regions   4.1 Global Percutaneous Transhepatic Cholangiography Consumption by Regions   4.2 North America Percutaneous Transhepatic Cholangiography Consumption (2014-2019)   4.3 Europe Percutaneous Transhepatic Cholangiography Consumption (2014-2019)   4.4 China Percutaneous Transhepatic Cholangiography Consumption (2014-2019)   4.5 Japan Percutaneous Transhepatic Cholangiography Consumption (2014-2019) 5 Global Percutaneous Transhepatic Cholangiography Production, Revenue, Price Trend by Type   5.1 Global Percutaneous Transhepatic Cholangiography Production Market Share by Type (2014-2019)   5.2 Global Percutaneous Transhepatic Cholangiography Revenue Market Share by Type (2014-2019)   5.3 Global Percutaneous Transhepatic Cholangiography Price by Type (2014-2019)   5.4 Global Percutaneous Transhepatic Cholangiography Production Growth by Type (2014-2019) 6 Global Percutaneous Transhepatic Cholangiography Market Analysis by Applications   6.1 Global Percutaneous Transhepatic Cholangiography Consumption Market Share by Application (2014-2019)   6.2 Global Percutaneous Transhepatic Cholangiography Consumption Growth Rate by Application (2014-2019) 7 Company Profiles and Key Figures in Percutaneous Transhepatic Cholangiography Business   7.1 B. Braun Melsungen AG   7.1.1 B. Braun Melsungen AG Percutaneous Transhepatic Cholangiography Production Sites and Area Served   7.1.2 Percutaneous Transhepatic Cholangiography Product Introduction, Application and Specification   7.1.3 B. Braun Melsungen AG Percutaneous Transhepatic Cholangiography Production, Revenue, Price and Gross Margin (2014-2019)   7.1.4 Main Business and Markets Served   7.2 KARL STORZ   7.2.1 KARL STORZ Percutaneous Transhepatic Cholangiography Production Sites and Area Served   7.2.2 Percutaneous Transhepatic Cholangiography Product Introduction, Application and Specification   7.2.3 KARL STORZ Percutaneous Transhepatic Cholangiography Production, Revenue, Price and Gross Margin (2014-2019)   7.2.4 Main Business and Markets Served   7.3 Cardinal Health   7.3.1 Cardinal Health Percutaneous Transhepatic Cholangiography Production Sites and Area Served   7.3.2 Percutaneous Transhepatic Cholangiography Product Introduction, Application and Specification   7.3.3 Cardinal Health Percutaneous Transhepatic Cholangiography Production, Revenue, Price and Gross Margin (2014-2019)   7.3.4 Main Business and Markets Served   7.4 GE Healthcare   7.4.1 GE Healthcare Percutaneous Transhepatic Cholangiography Production Sites and Area Served   7.4.2 Percutaneous Transhepatic Cholangiography Product Introduction, Application and Specification   7.4.3 GE Healthcare Percutaneous Transhepatic Cholangiography Production, Revenue, Price and Gross Margin (2014-2019)   7.4.4 Main Business and Markets Served 8 Percutaneous Transhepatic Cholangiography Manufacturing Cost Analysis   8.1 Percutaneous Transhepatic Cholangiography Key Raw Materials Analysis   8.1.1 Key Raw Materials   8.1.2 Price Trend of Key Raw Materials   8.1.3 Key Suppliers of Raw Materials   8.2 Proportion of Manufacturing Cost Structure   8.3 Manufacturing Process Analysis of Percutaneous Transhepatic Cholangiography   8.4 Percutaneous Transhepatic Cholangiography Industrial Chain Analysis 9 Marketing Channel, Distributors and Customers   9.1 Marketing Channel   9.1.1 Direct Marketing   9.1.2 Indirect Marketing   9.2 Percutaneous Transhepatic Cholangiography Distributors List   9.3 Percutaneous Transhepatic Cholangiography Customers 10 Market Dynamics   10.1 Market Trends   10.2 Opportunities   10.3 Market Drivers   10.4 Challenges   10.5 Influence Factors 11 Global Percutaneous Transhepatic Cholangiography Market Forecast   11.1 Global Percutaneous Transhepatic Cholangiography Production, Revenue Forecast   11.1.1 Global Percutaneous Transhepatic Cholangiography Production Growth Rate Forecast (2019-2025)   11.1.2 Global Percutaneous Transhepatic Cholangiography Revenue and Growth Rate Forecast (2019-2025)   11.1.3 Global Percutaneous Transhepatic Cholangiography Price and Trend Forecast (2019-2025)   11.2 Global Percutaneous Transhepatic Cholangiography Production Forecast by Regions (2019-2025)   11.2.1 North America Percutaneous Transhepatic Cholangiography Production, Revenue Forecast (2019-2025)   11.2.2 Europe Percutaneous Transhepatic Cholangiography Production, Revenue Forecast (2019-2025)   11.2.3 China Percutaneous Transhepatic Cholangiography Production, Revenue Forecast (2019-2025)   11.2.4 Japan Percutaneous Transhepatic Cholangiography Production, Revenue Forecast (2019-2025)   11.3 Global Percutaneous Transhepatic Cholangiography Consumption Forecast by Regions (2019-2025)   11.3.1 North America Percutaneous Transhepatic Cholangiography Consumption Forecast (2019-2025)   11.3.2 Europe Percutaneous Transhepatic Cholangiography Consumption Forecast (2019-2025)   11.3.3 China Percutaneous Transhepatic Cholangiography Consumption Forecast (2019-2025)   11.3.4 Japan Percutaneous Transhepatic Cholangiography Consumption Forecast (2019-2025)   11.4 Global Percutaneous Transhepatic Cholangiography Production, Revenue and Price Forecast by Type (2019-2025)   11.5 Global Percutaneous Transhepatic Cholangiography Consumption Forecast by Application (2019-2025) 12 Research Findings and Conclusion 13 Methodology and Data Source   13.1 Methodology/Research Approach   13.1.1 Research Programs/Design   13.1.2 Market Size Estimation   13.1.3 Market Breakdown and Data Triangulation   13.2 Data Source   13.2.1 Secondary Sources   13.2.2 Primary Sources   13.3 Author List   13.4 Disclaimer


--DocBreak--
For this reason, I'd expect the optimistic bias for the coronavirus to be smaller or absent in areas with high casualties where the virus has hit "close to home."


--DocBreak--
ImmunoGen Inc. [IMGN] has 160.00M shares outstanding, amounting to a total market cap of 545.60M. Its stock price has been found in the range of 1.76 to 7.07. At its current price, it has moved down by -51.77% from its 52-week high, and it has moved up 93.75% from its 52-week low.


--DocBreak--
Clinical care is changing faster than at any other time in my career. A big part of my job now is just keeping up. I consider how skeptical people were before COVID-19 that telemedicine visits could be acceptable because of ethical concerns, privacy issues and billing. Yet, in less than a week, video visits are up and running with the Centers for Medicare & Medicaid Services and the U.S. Department of Health and Human Services allowing health care institutions to use any video conferencing platform for patient care, including Skype and FaceTime.

